Research Progress on the Potential Role of Taurine in Cerebro-Metabolic Disease and its Mechanism

doi:10.3969/j.issn.1673-5765.2024.06.011

Abstract

Abstract: The concept of cerebro-metabolic disease, which centers on cerebrovascular damage caused by metabolic risk factors, has been proposed and is in the early stages of exploration. The prevention and treatment of cerebro-metabolic disease focus on the control of metabolic risk factors. At present, the clinical drug strategy is still based on the individual intervention of each metabolic risk factor, which brings a lot of trouble to patients due to the variety of drugs used and the high dosage. Therefore, there is an urgent need for a synergistic drug with multiple targets to reduce the drug burden and improve the efficacy in patients with cerebro-metabolic disease. Taurine, as a conditionally essential amino acid, has a variety of biological effects such as regulation of glycolipid metabolism, osmotic pressure regulation, cell membrane stabilization, antioxidation, anti-aging, etc., which has potential clinical value for cerebro-metabolic disease treatment. This paper focused on the pleiotropy of taurine and discussed the mechanism of taurine in cerebro-metabolic disease and its clinical application prospects.

Key words: Taurine; Cerebro-metabolic disease; Pleiotropy

摘要： 代谢性脑血管病以代谢危险因素引起的脑血管损害为核心，其概念已被提出并处于早期探索阶段。代谢性脑血管病的防治重点在于控制代谢危险因素，目前临床用药策略仍是对各个代谢危险因素进行单独干预，因用药种类多和剂量大给患者带来很多困扰。因此，临床亟需一种具有多作用靶点、可协同作用的药物以减少代谢性脑血管病患者的用药负担并提高疗效。牛磺酸作为一种条件必需氨基酸，具有调节糖脂代谢、调节渗透压、稳定细胞膜、抗氧化、抗衰老等多种生物学作用，对代谢性脑血管病治疗具有潜在临床价值。本文聚焦牛磺酸多效性，探讨牛磺酸在代谢性脑血管病中的作用机制及其临床应用前景。

关键词: 牛磺酸; 代谢性脑血管病; 多效性

CLC Number:

WEN Jiaqi, PANG Jiangxia, CHEN Chao, JIANG Changchun, HAO Xiwa. Research Progress on the Potential Role of Taurine in Cerebro-Metabolic Disease and its Mechanism[J]. Chinese Journal of Stroke, 2024, 19(6): 706-713.

温家琦, 庞江霞, 陈超, 姜长春, 郝喜娃. 牛磺酸在代谢性脑血管病中的潜在作用及其机制研究进展[J]. 中国卒中杂志, 2024, 19(6): 706-713.

References

[1] 许杰，王拥军. 代谢性脑血管病：概念、方法、挑战和未来方向[J]. 中国卒中杂志，2023，18（6）：617-627.
XU J，WANG Y J. Cerebro-metabolic disease：concept，method，challenge and future directions[J]. Chin J Stroke，2023，18（6）：617-627.
[2] TSAO C W，ADAY A W，ALMARZOOQ Z I，et al. Heart disease and stroke statistics—2022 update：a report from the American Heart Association[J/OL]. Circulation，2022，145（8）：e153-e639[2023-10-16]. https://doi.org/10.1161/cir.0000000000001052.
[3] GRUNDY S M. Metabolic syndrome update[J]. Trends Cardiovasc Med，2016，26（4）：364-373.
[4] ZHAO Z G，NIE H，HE H B，et al. High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome[J]. Metabolism，2007，56（12）：1612-1619.
[5] RAFIEE Z，GARCÍA-SERRANO A M，DUARTE J M N. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes[J/OL]. Nutrients，2022，14（6）：1292[2023-10-16]. https://doi.org/10.3390/nu14061292.
[6] SHIVARAJ M C，MARCY G，LOW G L，et al. Taurine induces proliferation of neural stem cells and synapse development in the developing mouse brain[J/OL]. PloS One，2012，7（8）：e42935[2023-10-16]. https://doi.org/10.1371/journal.pone.0042935.
[7] PARK E，PARK S Y，DOBKIN C，et al. Development of a novel cysteine sulfinic acid decarboxylase knockout mouse：dietary taurine reduces neonatal mortality[J/OL]. J Amino Acids，2014，2014：346809[2023-10-16]. https://doi.org/10.1155/2014/346809.
[8] MCGAUNN J，BAUR J A. Taurine linked with healthy aging[J]. Science，2023，380（6649）：1010-1011.
[9] MURAKAMI S. Taurine and atherosclerosis[J]. Amino acids，2014，46（1）：73-80.
[10] YANG J Y，ZHANG T T，YU Z L，et al. Taurine alleviates trimethylamine N-oxide-induced atherosclerosis by regulating bile acid metabolism in ApoE-/- mice[J]. J Agric Food Chem，2022，70（18）：5738-5747.
[11] AHMADIAN M，ROSHAN V D，ASLANI E，et al. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure[J]. Ther Adv Cardiovasc Dis，2017，11（7）：185-194.
[12] ROŞCA A E，VLĂDĂREANU A M，MIRICA R，et al. Taurine and its derivatives：analysis of the inhibitory effect on platelet function and their antithrombotic potential[J/OL]. J Clin Med，2022，11（3）：666[2023-10-16]. https://doi.org/10.3390/jcm11030666.
[13] JIN R，XIAO A Y，LIU S，et al. Taurine reduces tPA（tissue-type plasminogen activator）-induced hemorrhage and microvascular thrombosis after embolic stroke in rat[J]. Stroke，2018，49（7）：1708-1718.
[14] BALIOU S，ADAMAKI M，IOANNOU P，et al. Protective role of taurine against oxidative stress（review）[J/OL]. Mol Med Rep，2021，24（2）：605[2023-10-16]. https://doi.org/10.3892/mmr.2021.12242.
[15] RAFIEE Z，GARCÍA-SERRANO A M，DUARTE J M N. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes[J/OL]. Nutrients，2022，14（6）：1292[2023-10-16]. https://doi.org/10.3390/nu14061292.
[16] SEOL S I，KIM H J，CHOI E B，et al. Taurine protects against postischemic brain injury via the antioxidant activity of taurine chloramine[J/OL]. Antioxidants（Basel），2021，10（3）：372[2023-10-16]. https://doi.org/10.3390/antiox10030372.
[17] NIU X L，ZHENG S M，LIU H T，et al. Protective effects of taurine against inflammation，apoptosis，and oxidative stress in brain injury[J]. Mol Med Rep，2018，18（5）：4516-4522.
[18] LIBBY P. Inflammation in atherosclerosis[J]. Nature，2002，420（6917）：868-874.
[19] ABEBE W，MOZAFFARI M S. Role of taurine in the vasculature：an overview of experimental and human studies[J]. Am J Cardiovasc Dis，2011，1（3）：293-311.
[20] KIM K S，OH D H，KIM J Y，et al. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty（OLETF）rats with long-term diabetes[J]. Exp Mol Med，2012，44（11）：665-673.
[21] MURAKAMI S，KONDO Y，NAGATE T. Effects of long-term treatment with taurine in mice fed a high-fat diet：improvement in cholesterol metabolism and vascular lipid accumulation by taurine[J/OL]. Adv Exp Med Biol，2000，483：177-186[2023-10-16]. https://doi.org/10.1007/0-306-46838-7_19.
[22] GUIZONI D M，VETTORAZZI J F，CARNEIRO E M，et al. Modulation of endothelium-derived nitric oxide production and activity by taurine and taurine-conjugated bile acids[J/OL]. Nitric Oxide，2020，94：48-53[2023-10-16]. https://doi.org/10.1016/j.niox.2019.10.008.
[23] ZHAO D D，LV Q F，YANG J C，et al. Taurine improves lipid metabolism and skeletal muscle sensitivity to insulin in rats fed with high sugar and high fat diet[J/OL]. Adv Exp Med Biol，2019，1155：133-146[2023-10-16]. https://doi.org/10.1007/978-981-13-8023-5_12.
[24] WEN C Y，LI F N，ZHANG L Y，et al. Taurine is involved in energy metabolism in muscles，adipose tissue，and the liver[J/OL]. Mol Nutr Food Res，2019，63（2）：e1800536[2023-10-16]. https://doi.org/10.1002/mnfr.201800536.
[25] CHIANG J Y L. Bile acid metabolism and signaling[J]. Compr Physiol，2013，3（3）：1191-1212.
[26] MOZAFFARI M S，PATEL C，ABDELSAYED R，et al. Accelerated NaCl-induced hypertension in taurine-deficient rat：role of renal function[J]. Kidney Int，2006，70（2）：329-337.
[27] ESMAEILI F，MALEKI V，KHEIROURI S，et al. The effects of taurine supplementation on metabolic profiles，pentosidine，soluble receptor of advanced glycation end products and methylglyoxal in adults with type 2 diabetes：a randomized，double-blind，placebo-controlled trial[J]. Can J Diabetes，2021，45（1）：39-46.
[28] MALEKI V，ALIZADEH M，ESMAEILI F，et al. The effects of taurine supplementation on glycemic control and serum lipid profile in patients with type 2 diabetes：a randomized，double-blind，placebo-controlled trial[J]. Amino Acids，2020，52（6/7）：905-914.
[29] SUN Q Q，WANG B，LI Y S，et al. Taurine supplementation lowers blood pressure and improves vascular function in prehypertension：randomized，double-blind，placebo-controlled study[J]. Hypertension，2016，67（3）：541-549.
[30] YAMORI Y，TAGUCHI T，MORI H，et al. Low cardiovascular risks in the middle aged males and females excreting greater 24-hour urinary taurine and magnesium in 41 WHO-CARDIAC study populations in the world[J/OL]. J Biomed Sci，2010，17 Suppl 1（Suppl 1）：S21[2023-10-16]. https://doi.org/10.1186/1423-0127-17-S1-S21.
[31] STOREY K B，STOREY J M，BROOKS S P，et al. Hatchling turtles survive freezing during winter hibernation[J]. Proc Natl Acad Sci U S A，1988，85（21）：8350-8354.
[32] JEYNES B J. Combined streptokinase and taurochenodeoxycholate action on experimentally induced atherothromboemboli. Chandler tube study[J]. Arch Pathol Lab Med，1986，110（12）：1143-1148.
[33] JEYNES B J. Treatment of experimentally induced cerebral atherothromboembolism in an animal model with streptokinase and taurochenodeoxycholate[J]. Artery，1988，15（5）：259-271.
[34] IJIRI Y，IKARUGI H，TAMURA Y，et al. Antithrombotic effect of taurine in healthy Japanese people may be related to an increased endogenous thrombolytic activity[J]. Thromb Res，2013，131（2）：158-161.
[35] FRANCONI F，BENNARDINI F，MATTANA A，et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus：effects of taurine supplementation[J]. Am J Clin Nutr，1995，61（5）：1115-1119.
[36] ALKAHTANI R. Molecular mechanisms underlying some major common risk factors of stroke[J/OL]. Heliyon，2022，8（8）：e10218[2023-10-16]. https://doi.org/10.1016/j.heliyon.2022.e10218.
[37] SU Z Z，YE Y Z，SHEN C E，et al. Pathophysiology of ischemic stroke：noncoding RNA role in oxidative stress[J/OL]. Oxid Med Cell Longev，2022，2022：5815843[2023-10-16]. https://doi.org/10.1155/2022/5815843.
[38] HANNAWI Y. Cerebral small vessel disease：a review of the pathophysiological mechanisms[J/OL]. Transl Stroke Res，2023[2023-10-16]. https://doi.org/10.1007/s12975-023-01195-9.
[39] YAMORI Y，TAGUCHI T，HAMADA A，et al. Taurine in health and diseases：consistent evidence from experimental and epidemiological studies[J/OL]. J Biomed Sci，2010，17 Suppl 1（Suppl 1）：S6[2023-10-16]. https://doi.org/10.1186/1423-0127-17-S1-S6.
[40] WU J Y，PRENTICE H. Role of taurine in the central nervous system[J/OL]. J Biomed Sci，2010，17 Suppl 1（Suppl 1）：S1[2023-10-16]. https://doi.org/10.1186/1423-0127-17-S1-S1.
[41] SUN M，ZHAO Y，GU Y，et al. Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB[J]. Amino Acids，2012, 42（5），1735-1747.
[42] ZHAO H L，QU J，LI Q，et al. Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats[J]. Amino Acids，2018，50（3/4）：439-451.
[43] SHETEWY A，SHIMADA-TAKAURA K，WARNER D，et al. Mitochondrial defects associated with β-alanine toxicity：relevance to hyper-beta-alaninemia[J]. Mol Cell Biochem，2016，416（1/2）：11-22.
[44] SEIDEL U，HUEBBE P，RIMBACH G. Taurine：a regulator of cellular redox homeostasis and skeletal muscle function[J/OL]. Mol Nutr Food Res，2019，63（16）：e1800569[2023-10-16]. https://doi.org/10.1002/mnfr.201800569.
[45] PARVEZ S，TABASSUM H，BANERJEE B D，et al. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice[J]. Basic Clin Pharmacol Toxicol，2008，102（4）：382-387.
[46] RODRIGUES C M，SPELLMAN S R，SOLÁ S，et al. Neuroprotection by a bile acid in an acute stroke model in the rat[J]. J Cereb Blood Flow Metab，2002，22（4）：463-471.
[47] RODRIGUES C M，SOLA S，NAN Z H，et al. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats[J]. Proc Natl Acad Sci U S A，2003，100（10）：6087-6092.
[48] VAHDAT M，HOSSEINI S A，SOLTANI F，et al. The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury：a double-blind randomized controlled trial[J/OL]. Nutr J，2021，20（1）：53[2023-10-16]. https://doi.org/10.1186/s12937-021-00712-6.
[49] KOUTSALIARIS I K，MOSCHONAS I C，PECHLIVANI L M，et al. Inflammation，oxidative stress，vascular aging and atherosclerotic ischemic stroke[J]. Curr Med Chem，2022，29（34）：5496-5509.
[50] SINGH P，GOLLAPALLI K，MANGIOLA S，et al. Taurine deficiency as a driver of aging[J/OL]. Science，2023，380（6649）：eabn9257[2023-10-16]. https://doi.org/10.1126/science.abn9257.
[51] JUN H，CHOI M J. Relationship between taurine intake and cardiometabolic risk markers in Korean elderly[J/OL]. Adv Exp Med Biol，2019，1155：301-311[2023-10-16]. https://doi.org/10.1007/978-981-13-8023-5_29.
[52] ABUD G F，DE CARVALHO F G，BATITUCCI G，et al. Taurine as a possible antiaging therapy：a controlled clinical trial on taurine antioxidant activity in women ages 55 to 70[J/OL]. Nutrition，2022，101：111706[2023-10-16]. https://doi.org/10.1016/j.nut.2022.111706.
[53] LEWIS G F，CARPENTIER A，ADELI K，et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes[J]. Endocr Rev，2002，23（2）：201-229.
[54] SEMOVA I，LEVENSON A E，KRAWCZYK J，et al. Insulin prevents hypercholesterolemia by suppressing 12α-hydroxylated bile acids[J]. Circulation，2022，145（13）：969-982.
[55] HOTAMISLIGIL G S. Inflammation and metabolic disorders[J]. Nature，2006，444（7121）：860-867.
[56] 赵敬堃，王建秀，段淑荣. 牛磺酸治疗高同型半胱氨酸脑梗死患者动脉粥样硬化的临床观察[J]. 中华神经医学杂志，2009，8（10）：1035-1037.
ZHAO J K，WANG J X，DUAN S R. Effect of taurine on atherosclerosis in patients with cerebral infarction induced by hyperhomocysteinemia[J]. Chin J Neuromed，2009，8（10）：1035-1037.
[57] FENG Y，SUN F，GAO Y C，et al. Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injury[J]. Biochem Biophys Res Commun，2017，489（3）：312-318.